Patent: 10,398,734
✉ Email this page to a colleague
Summary for Patent: 10,398,734
| Title: | Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy |
| Abstract: | The present invention provides improved and/or shortened methods for expanding TILs and producing therapeutic populations of TILs, including novel methods for expanding TIL populations in a closed system that lead to improved efficacy, improved phenotype, and increased metabolic health of the TILs in a shorter time period, while allowing for reduced microbial contamination as well as decreased costs. Such TILs find use in therapeutic treatment regimens. |
| Inventor(s): | Seth Wardell, James Bender, Michael T. Lotze |
| Assignee: | Iovance Biotherapeutics Inc |
| Application Number: | US16/201,957 |
| Patent Claims: | see list of patent claims |
| Patent landscape, scope, and claims summary: |
More… ↓ |
Details for Patent 10,398,734
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Iovance Biotherapeutics, Inc. | AMTAGVI | lifileucel | Suspension | 125773 | February 16, 2024 | ⤷ Start Trial | 2038-11-27 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 10,398,734
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2018182817 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 2019190579 | ⤷ Start Trial |
| United States of America | 10130659 | ⤷ Start Trial |
| United States of America | 10166257 | ⤷ Start Trial |
| United States of America | 10272113 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
